
Abbisko Cayman Ltd
HKEX:2256

Abbisko Cayman Ltd?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
2.74
10.84
|
Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Abbisko Cayman Ltd hold over its rivals?
What risks and challenges
does Abbisko Cayman Ltd face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Abbisko Cayman Ltd.
Provide an overview of the primary business activities
of Abbisko Cayman Ltd.
What unique competitive advantages
does Abbisko Cayman Ltd hold over its rivals?
What risks and challenges
does Abbisko Cayman Ltd face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Abbisko Cayman Ltd.
Provide P/S
for Abbisko Cayman Ltd.
Provide P/E
for Abbisko Cayman Ltd.
Provide P/OCF
for Abbisko Cayman Ltd.
Provide P/FCFE
for Abbisko Cayman Ltd.
Provide P/B
for Abbisko Cayman Ltd.
Provide EV/S
for Abbisko Cayman Ltd.
Provide EV/GP
for Abbisko Cayman Ltd.
Provide EV/EBITDA
for Abbisko Cayman Ltd.
Provide EV/EBIT
for Abbisko Cayman Ltd.
Provide EV/OCF
for Abbisko Cayman Ltd.
Provide EV/FCFF
for Abbisko Cayman Ltd.
Provide EV/IC
for Abbisko Cayman Ltd.
Show me price targets
for Abbisko Cayman Ltd made by professional analysts.
What are the Revenue projections
for Abbisko Cayman Ltd?
How accurate were the past Revenue estimates
for Abbisko Cayman Ltd?
What are the Net Income projections
for Abbisko Cayman Ltd?
How accurate were the past Net Income estimates
for Abbisko Cayman Ltd?
What are the EPS projections
for Abbisko Cayman Ltd?
How accurate were the past EPS estimates
for Abbisko Cayman Ltd?
What are the EBIT projections
for Abbisko Cayman Ltd?
How accurate were the past EBIT estimates
for Abbisko Cayman Ltd?
Compare the revenue forecasts
for Abbisko Cayman Ltd with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Abbisko Cayman Ltd and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Abbisko Cayman Ltd against its competitors.
Analyze the profit margins
(gross, operating, and net) of Abbisko Cayman Ltd compared to its peers.
Compare the P/E ratios
of Abbisko Cayman Ltd against its peers.
Discuss the investment returns and shareholder value creation
comparing Abbisko Cayman Ltd with its peers.
Analyze the financial leverage
of Abbisko Cayman Ltd compared to its main competitors.
Show all profitability ratios
for Abbisko Cayman Ltd.
Provide ROE
for Abbisko Cayman Ltd.
Provide ROA
for Abbisko Cayman Ltd.
Provide ROIC
for Abbisko Cayman Ltd.
Provide ROCE
for Abbisko Cayman Ltd.
Provide Gross Margin
for Abbisko Cayman Ltd.
Provide Operating Margin
for Abbisko Cayman Ltd.
Provide Net Margin
for Abbisko Cayman Ltd.
Provide FCF Margin
for Abbisko Cayman Ltd.
Show all solvency ratios
for Abbisko Cayman Ltd.
Provide D/E Ratio
for Abbisko Cayman Ltd.
Provide D/A Ratio
for Abbisko Cayman Ltd.
Provide Interest Coverage Ratio
for Abbisko Cayman Ltd.
Provide Altman Z-Score Ratio
for Abbisko Cayman Ltd.
Provide Quick Ratio
for Abbisko Cayman Ltd.
Provide Current Ratio
for Abbisko Cayman Ltd.
Provide Cash Ratio
for Abbisko Cayman Ltd.
What is the historical Revenue growth
over the last 5 years for Abbisko Cayman Ltd?
What is the historical Net Income growth
over the last 5 years for Abbisko Cayman Ltd?
What is the current Free Cash Flow
of Abbisko Cayman Ltd?
Discuss the annual earnings per share (EPS)
trend over the past five years for Abbisko Cayman Ltd.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
CN |
![]() |
Abbisko Cayman Ltd
HKEX:2256
|
7.4B HKD | 45.5 | |
FR |
![]() |
Pharnext SCA
OTC:PNEXF
|
6T USD | -195 934.6 |
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
327.5B USD | 15 |
|
US |
![]() |
Amgen Inc
NASDAQ:AMGN
|
150.7B USD | 13.8 |
|
US |
![]() |
Gilead Sciences Inc
NASDAQ:GILD
|
131.9B USD | 9.7 |
|
US |
![]() |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
114.6B USD | 24.6 |
|
US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | -576.6 |
|
AU |
![]() |
CSL Ltd
ASX:CSL
|
116.3B AUD | 17.1 |
|
US |
![]() |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
56.3B USD | 11.1 |
|
US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | -66.1 |
|
US |
![]() |
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
42B USD | -697.8 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
CN |
![]() |
Abbisko Cayman Ltd
HKEX:2256
|
Average EV/EBITDA:
19.5
45.5
|
N/A | N/A | |
FR |
![]() |
Pharnext SCA
OTC:PNEXF
|
Negative Multiple: -195 934.6 | N/A | N/A |
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
15
|
13%
|
1.2 |
|
US |
![]() |
Amgen Inc
NASDAQ:AMGN
|
13.8
|
17%
|
0.8 |
|
US |
![]() |
Gilead Sciences Inc
NASDAQ:GILD
|
9.7
|
6%
|
1.6 |
|
US |
![]() |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
24.6
|
17%
|
1.4 |
|
US |
E
|
Epizyme Inc
F:EPE
|
Negative Multiple: -576.6 | N/A | N/A |
|
AU |
![]() |
CSL Ltd
ASX:CSL
|
17.1
|
11%
|
1.6 |
|
US |
![]() |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
11.1
|
11%
|
1 |
|
US |
S
|
Seagen Inc
F:SGT
|
Negative Multiple: -66.1 | N/A | N/A |
|
US |
![]() |
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
Negative Multiple: -697.8 | N/A | N/A |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.